LONDON, Jan. 17, 2020 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to...
Verona Pharma PLC 13 January 2020 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this...
Verona Pharma PLC 13 January 2020 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call...
Verona Pharma PLC on Monday said its Phase 2b clinical trial of nebulized Ensifentrine met its primary endpoint. The ...
Primary endpoint met at all doses: ensifentrine produced clinically and statistically significant dose-dependent improvements in lung function...
Data release and conference call on Monday January 13, 2020 LONDON, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA...
LONDON, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) ("Verona Pharma"), a clinical-stage...
LONDON, Nov. 28, 2019 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to...
LONDON, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a biopharmaceutical company...
LONDON, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...
LONDON, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...
LONDON, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) ("Verona Pharma"), a clinical-stage...
LONDON, Nov. 11, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) ("Verona Pharma"), a clinical-stage...
Verona Pharma PLC on Tuesday said its loss widened considerably in the third quarter of 2019, dragged down as researc ...
Reported positive Phase 2 data with dry powder inhaler formulation Post period end, completed enrollment in Phase 2b study with nebulized...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.